We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
+7.19%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$836M
AUM Growth
+$219M
Cap. Flow
+$188M
Cap. Flow %
22.5%
Top 10 Hldgs %
4.49%
Holding
1,220
New
441
Increased
247
Reduced
213
Closed
319

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$4.41M
2
AAP icon
Advance Auto Parts
AAP
+$4.15M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.96M
4
DLTR icon
Dollar Tree
DLTR
+$3.82M
5
MSFT icon
Microsoft
MSFT
+$3.74M

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$2.82M
2
KO icon
Coca-Cola
KO
+$2.82M
3
GD icon
General Dynamics
GD
+$2.82M
4
ORCL icon
Oracle
ORCL
+$2.81M
5
HLNE icon
Hamilton Lane
HLNE
+$2.8M

Sector Composition

Rank Sector Weight
1 Technology 16.51%
2 Industrials 15.72%
3 Consumer Discretionary 15.68%
4 Healthcare 13.43%
5 Financials 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NSA
251
DELISTED
National Storage Affiliates Trust
NSA
$1.14M 0.14%
23,554
+15,905
+208% +$710K
CDNA icon
252
CareDx
CDNA
$1.88B
$1.13M 0.14%
36,345
+6,471
+22% +$161K
AME icon
253
Ametek
AME
$55.7B
$1.13M 0.14%
6,597
+3,983
+152% +$665K
SIGI icon
254
Selective Insurance
SIGI
$5.53B
$1.13M 0.14%
+12,109
New +$1.09M
WLY icon
255
John Wiley & Sons Class A
WLY
$2.59B
$1.13M 0.13%
+23,352
New +$1.07M
MGEE icon
256
MGE Energy Inc
MGEE
$3.08B
$1.12M 0.13%
12,281
+1,307
+12% +$112K
TKO icon
257
TKO Group
TKO
$13.7B
$1.12M 0.13%
+9,072
New +$1.04M
CVS icon
258
CVS Health
CVS
$137B
$1.12M 0.13%
+17,758
New +$1.04M
OSIS icon
259
OSI Systems
OSIS
$3.58B
$1.11M 0.13%
+7,320
New +$1.05M
OUT icon
260
Outfront Media
OUT
$5.68B
$1.11M 0.13%
61,420
-28,401
-32% -$451K
EVTC icon
261
Evertec
EVTC
$1.88B
$1.11M 0.13%
+32,681
New +$1.09M
FDX icon
262
FedEx
FDX
$73.5B
$1.11M 0.13%
+4,043
New +$1.17M
MLI icon
263
Mueller Industries
MLI
$14.2B
$1.1M 0.13%
29,744
-8,320
-22% -$279K
BRKR icon
264
Bruker
BRKR
$9.14B
$1.1M 0.13%
15,929
-6,331
-28% -$409K
JKHY icon
265
Jack Henry & Associates
JKHY
$10.9B
$1.09M 0.13%
+6,177
New +$1.05M
ED icon
266
Consolidated Edison
ED
$41.1B
$1.08M 0.13%
+10,380
New +$1.03M
LIVN icon
267
LivaNova
LIVN
$4.43B
$1.07M 0.13%
20,413
+14,452
+242% +$716K
PARR icon
268
Par Pacific Holdings
PARR
$3.94B
$1.07M 0.13%
60,864
+32,877
+117% +$734K
RUN icon
269
Sunrun
RUN
$2.38B
$1.07M 0.13%
+59,302
New +$1.05M
NOC icon
270
Northrop Grumman
NOC
$77.8B
$1.07M 0.13%
2,020
+123
+6% +$60.2K
PLYM
271
DELISTED
Plymouth Industrial REIT
PLYM
$1.06M 0.13%
47,112
+34,233
+266% +$796K
TPH
272
DELISTED
Tri Pointe Homes
TPH
$1.06M 0.13%
23,480
+7,460
+47% +$319K
LLYVK icon
273
Liberty Live Group Series C
LLYVK
$9.41B
$1.06M 0.13%
20,677
+9,330
+82% +$373K
SAND
274
DELISTED
Sandstorm Gold
SAND
$1.06M 0.13%
176,537
+92,414
+110% +$525K
MNRO icon
275
Monro
MNRO
$529M
$1.06M 0.13%
36,630
+27,200
+288% +$703K
9 10
11
12 13

Similar funds

SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return

Nebula Research & Development's Q3 2024 Portfolio in Review

As of Q3 2024, Nebula Research & Development held 1,220 positions worth $836M, up 35% from $618M the previous quarter. Its ten largest holdings account for 4.5% of the portfolio.

Nebula Research & Development deployed $188M of net new capital in Q3 2024, opening 441 new positions and adding to 247 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Travelers Companies, an estimated $2.39M trimmed.

  • Nebula Research & Development's largest Q3 2024 buy was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.
  • Nebula Research & Development added most to Dollar Tree in Q3 2024, an estimated $3.82M increase.
  • Nebula Research & Development's biggest Q3 2024 reduction was Travelers Companies, cutting an estimated $2.39M.
  • Nebula Research & Development fully exited Bank of America in Q3 2024, selling an estimated $2.82M.
  • Nebula Research & Development's ten largest holdings make up 4.5% of its $836M portfolio in Q3 2024.
  • Nebula Research & Development opened 441 new positions and closed 319 in Q3 2024.
  • Nebula Research & Development's portfolio value rose 35% quarter-over-quarter to $836M.

Based on Nebula Research & Development's 13F filing for Q3 2024, filed 14 Nov 2024.